COVID: Clinical Trials

3 trials for COVID, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Terminated 3

Follow COVID: new trials by email Literature Review of COVID trials Research Report on COVID

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization
Sodium bicarbonate, Standard of Care - COVID, Coronavirus
Phase 4TerminatedWest Virginia University32020-10-052023-12-22
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism
TNKase, Placebo, Enoxaparin - Pulmonary Embolism, COVID
Phase 4TerminatedCedars-Sinai Medical Center22020-09-082021-10-26
Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease
Valsartan (Diovan), Placebo oral tablet - Acute Respiratory Distress Syndrome, SARS-CoV-2
Phase 4TerminatedRadboud University Medical Center232020-04-172021-09-24

Narrower conditions

COVID-19 (2)  ·  Acute Kidney Injury (1)  ·  Coronavirus Infections (1)  ·  Pulmonary Embolism (1)  ·  Respiratory Distress Syndrome (1)  ·  Severe Acute Respiratory Syndrome (1)

Broader conditions

Lung Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Coronaviridae Infections (2)  ·  Infections (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Coronavirus Infections (1)  ·  Embolism (1)  ·  Embolism and Thrombosis (1)  ·  Female Urogenital Diseases (1)

Interventions

Enoxaparin (1)  ·  Heparin (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Sodium Bicarbonate (1)  ·  Standard of Care (1)  ·  Tenecteplase (1)  ·  Valsartan (1)  ·  enoxaparin sodium (1)

Sponsors

Cedars-Sinai Medical Center (1)  ·  Radboud University Medical Center (1)  ·  West Virginia University (1)

Countries

United States (2)  ·  Netherlands (1)

Top investigators

Ankit Sakhuja, MD (1)  ·  Niels van Royen, MD PhD (1)  ·  Victor E Tapson, MD (1)

Results publications

PMID 32512291